Zydus Bio. - search results

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

telmisartan 40 zydus tablets

zydus healthcare (pty) ltd - tablets - not indicated - each tablet contains telmisartan 40,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

telmisartan 80 zydus tablets

zydus healthcare (pty) ltd - tablets - not indicated - each tablet contains telmisartan 80,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dapagliflozin 5 zydus tablet

zydus healthcare (pty) ltd - tablet - see ingredients - each tablet contains dapagliflozin 5,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

dapagliflozin 10 zydus tablet

zydus healthcare (pty) ltd - tablet - see ingredients - each tablet contains dapagliflozin 10,0 mg

United States - English - NLM (National Library of Medicine)

sucralfate tablet

zydus lifesciences limited - sucralfate (unii: xx73205dh5) (sucralfate - unii:xx73205dh5) - sucralfate tablets are indicated in: - short-term treatment (up to 8 weeks) of active duodenal ulcer. while healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. sucralfate tablets are contraindicated in patients with known hypersensitivity reactions to the active substance or to any of the excipients.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sitagliptin 25 zydus #n/a